Big Move For Stoke Therapeutics, Inc.
Tue, Mar 26, 2024 at 07:19 PM
Stoke Therapeutics, Inc. (STOK:NASDAQ) shot up at $10.29, representing a gain of 58.3%. On Tue, Mar 26, 2024, STOK:NASDAQ hit a New 2-Week High of $10.29. The stock got featured on our News Catalysts scanner on Tue, Mar 26, 2024 at 06:20 PM in the 'PUBLIC OFFERING' category. From Tue, Mar 12, 2024, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue, Mar 26, 2024 at $13 with a volume of 18M+.
About Stoke Therapeutics, Inc. (STOK:NASDAQ)
Stoke Therapeutics Inc is engaged in developing antisense oligonucleotide medicines. The medicine increases gene expression to treat genetic epilepsies and other severe monogenic diseases, including genetic conditions affecting the central nervous system, eye, liver and kidney.
Top 10 Gainers:
- SRAX, Inc. (SRAX:NASDAQ), 111.11%
- Mesoblast Limited (MESO:NASDAQ), 78.64%
- Cazoo Group Ltd Class A (CZOO:NYSE), 61.08%
- Stoke Therapeutics, Inc. (STOK:NASDAQ), 58.31%
- OpGen, Inc. (OPGN:NASDAQ), 57.86%
- Concord Medical Services Holdings Limited (CCM:NYSE), 47.66%
- Krispy Kreme Inc. (DNUT:NASDAQ), 39.36%
- C3is Inc. (CISS:NASDAQ), 36.65%
- AirNet Technology Inc. (ANTE:NASDAQ), 34.15%
- Puyi Inc. (PUYI:NASDAQ), 33.93%